ZEFFIX 5 mg/ml, oral solution bottle, 240 ml
Active ingredients: Lamivudine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Oral solutionbottle, 240 mlorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- ZEFFIX 5 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 240 ml avec adaptateur(s) pour flacon polyéthylène
- Marketing authorisation holder
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Aug 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68427877CIP73519694CIP133400935196941Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LAMIVUDINEsolution | 5 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.